IRCT20210609051526N2招募中3 期
Effect of Empagliflozin on Liver Enzymes level in type two Diabetic Patients with Non-Alcoholic Steatohepatitis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 85 years（—）
- 性别
- All
入选标准
- •Body mass index less than 35 Kg/mm
- •No history of chronic alcohol usage
- •No history of viral hepatities
- •No history of autoimmune hepatitis
- •No history of drug-induced hepatitis
- •No history of chronic usage of hepatic-steatosis-induced drugs(e.g.: Amiodarone, Valproate, Tamoxifen, Methotrexate, Glucocorticoids)
- •No history of chronic usage of Thiazolidines and GLP-1 agonists
- •Absence of evidence suggestive for cirrhosis based on physical examination, laboratory evaluation, and imaging studies
- •Absence of evidence suggestive for Hepatocellular carcinoma based on physical examination, laboratory evaluation, and imaging studies
- •Non pregnant women
- •No previous history of HELLP syndrome in women
- •No history of chronic kidney disease
- •No history of chronic usage of Omega-3 containing supplements
- •No contraindication for Empagliflozin usage (e.g.: history of recurrent genitourinary tract infection, gangrene, history of allergic reaction to the drug, serum Trigliceride level more than 500 mg/dl)
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
The effect of ertugliflozin in patients with nonalcoholic fatty liver disease (NAFLD) associated with type 2 diabetes mellitus.Fatty liver diseasesElevated liver enzymesNon alcoholic acute Steatohepatitis (NASH)Metabolic and Endocrine - Metabolic disordersMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonObesityInsulin resistanceACTRN12624000032550Abdul Wali Khan University180
已完成
4 期
Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 DiabetesNon-alcoholic Fatty Liver DiseaseType 2 DiabetesNCT02637973The Deutsche Diabetes Forschungsgesellschaft e.V.84
已完成
3 期
Evaluation Liverghol Impact on Liver EnzymesThalassemiaIRCT20150119020715N9Arak University of Medical Sciences40
招募中
3 期
Evaluation effect of Empagliflozin in psychiatric disordersIRCT20180404039187N9Tabriz University of Medical Sciences40
已完成
3 期
The effect of empagliflozin laboratory findingsCondition 1: Diabetes Mellitus type 2. Condition 2: Coronary artery disease.Type 2 diabetes mellitusAtherosclerotic heart disease of native coronary arteryI125.1IRCT20190412043247N1Zanjan University of Medical Sciences100